Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | FPR2 | P25090 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2230916 | 1.00 | TP53 (0.41) | TP53SLC7A5ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL8351936 | 1.00 | TP53 (0.41) | TP53SLC7A5ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL43661 | 0.81 | — | — | |
| SCHEMBL43660 | 0.81 | — | — | |
| SCHEMBL716843 | 0.81 | SMN1; SMN2 (0.41) | TP53SLC7A5ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL161931 | 0.81 | — | — | |
| SCHEMBL19080635 | 0.79 | — | — | |
| SCHEMBL21621510 | 0.79 | — | — | |
| SCHEMBL312336 | 0.79 | — | — | |
| SCHEMBL21673293 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6270957-B1 | USEFUL IN THE TREATMENT AND PREVENTION OF HIV (HUMAN IMMUNODEFICIENCY VIRUS)-MEDIATED DISORDERS, INCLUDING AIDS (ACQUIRE IMMUNODEFICIENCY SYNDROME) | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-08-07 | — | — | US | claimed |
| WO-1999010373-B1 | NON-IMMUNOSUPPRESSIVE CYCLOSPORINS AND THEIR USE IN THE PREVENTION AND TREATMENT OF HIV INFECTION | WISCONSIN ALUMNI RES FOUND (US) | 1999-04-01 | — | — | WO | claimed |
| WO-1999010373-A1 | NON-IMMUNOSUPPRESSIVE CYCLOSPORINS AND THEIR USE IN THE PREVENTION AND TREATMENT OF HIV INFECTION | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-03-04 | — | — | WO | claimed |
| EP-4100007-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | The Regents of the University of California (US) | 2022-12-14 | — | — | EP | disclosed |
| WO-2021158899-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-08-12 | — | — | WO | disclosed |
| US-20110201642-A1 | Bioactive Compounds | BLUNT JOHN | 2011-08-18 | — | — | US | disclosed |
| EP-2352746-A1 | BIOACTIVE COMPOUNDS | Universiti Teknologi Mara (MY) | 2011-08-10 | — | — | EP | disclosed |
| WO-2010062159-A1 | BIOACTIVE COMPOUNDS | UNIVERSITI TEKNOLOGI MARA (MY) | 2010-06-03 | — | — | WO | disclosed |
| US-6316405-B1 | CYCLOSPORIN A, POLYPEPTIDES, COMPONENT OF AMYLOID PLAQUES FOUND IN NEUROLOGICAL DISORDERS SUCH AS ALZHEIMER'S DISEASE, MULTIPLE SCLEROSIS, AND AMYOTROPHIC LATERAL SCLEROSIS. THE CONJUGATES ARE USEFUL IN THE TREATMENT OF NEUROLOGICAL | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-11-13 | — | — | US | disclosed |
| US-6270957-B1 | USEFUL IN THE TREATMENT AND PREVENTION OF HIV (HUMAN IMMUNODEFICIENCY VIRUS)-MEDIATED DISORDERS, INCLUDING AIDS (ACQUIRE IMMUNODEFICIENCY SYNDROME) | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-08-07 | — | — | US | disclosed |
| US-5948693-A | COVALENTLY BONDING SIDE CHAIN OF SELECTED AMINO ACID TO SOLID SUPPORT VIA ACID-LABILE OR PHOTO-LABILE LINKER, PROTECTING C-TERMINUS, SYNTHESIZING POLYPEPTIDE ON N-TERMINUS, DEPROTECTING C-TERMINUS AND CYCLIZING POLYPEPTIDE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-09-07 | — | — | US | disclosed |
| WO-1999010374-A1 | CYCLOSPORIN A CONJUGATES AND USES THEREFOR | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-03-04 | — | — | WO | disclosed |
| WO-1999010373-A1 | NON-IMMUNOSUPPRESSIVE CYCLOSPORINS AND THEIR USE IN THE PREVENTION AND TREATMENT OF HIV INFECTION | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-03-04 | — | — | WO | disclosed |
| WO-1998046247-A1 | SOLID PHASE SYNTHESIS OF IMMUNOSUPPRESSIVE AGENTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1998-10-22 | — | — | WO | disclosed |
| EP-0778847-A4 | IMMUNOSTIMULATORY AGENTS | WISCONSIN ALUMNI RES FOUND (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0778847-A1 | IMMUNOSTIMULATORY AGENTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1997-06-18 | — | — | EP | disclosed |
| US-5639852-A | ANALOGS OF CYCLOSPORIN A | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1997-06-17 | — | — | US | disclosed |
| WO-1996006857-A1 | IMMUNOSTIMULATORY AGENTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1996-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201642-A1 | Bioactive Compounds | TPI1, XPO1, GDI1 | TP53 291/4885SLC7A5 3811/4885ALDH1A1 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.